Newsroom

How Cidara Got Its Molecule Back Oct 30, 2024
Cidara buys back flu rights, sells antifungal and inks $240M PIPE Apr 24, 2024
Cidara regains rights to flu med after Janssen makes good on promise to divest Apr 2024
New Treatment Pathways for CD73-Expressing Tumors Nov 24, 2023
Cidara’s J&J-partnered immunotherapy could target flu and cancer  Oct 26, 2023
Cidara gets US FDA approval for antifungal drug Mar 22, 2023
Deadly Fungus, Candida Auris, Spreading Across U.S. in Healthcare Facilities, CDC Says Mar 21, 2023
FDA adcomm votes in favor of new antifungal Jan 25, 2023
Fatal Fungi Threaten Global Health, WHO Says Oct 26, 2022
San Diego antifungal player nabs priority review for bloodstream infection treatment Sep 21, 2022
Jeff Stein, President & CEO of Cidara Therapeutics Shares Insights on the P-III ReSTORE Trial of Rezafungin to Treat Candidemia Aug 30, 2022
PharmaShots Interview: In Conversation with Cidara’s CEO, Dr.Jeff Stein, Where he Shares Insights on the IND acceptance by the FDA to Treat Influenza Jun 6, 2022
4 Things to Know About the Flu in the Time of COVID-19 Jan 18, 2022
Emerging Drug-Resistant Fungi Threat Offset by Cidara’s Phase III Antifungal Therapy Jul 29, 2021
Johnson & Johnson Trying to Prevent Next Pandemic by Funding AVC Research* Apr 16, 2021
J&J Bets Up to $780 Million on Cidara’s Universal Influenza Treatment Apr 5, 2021
With one pandemic still raging, J&J bets $780M on a potential flu therapy for the next Apr 5, 2021
Janssen taps Cidara to develop new antiviral immunotherapies for flu Apr 5, 2021
Pioneering Antiviral Conjugates With Cidara’s Dr. Jeff Stein Mar 1, 2021
The Fight Against Fungi Mar 1, 2021
Scrip Asks…What Does 2021 Hold For Biopharma? Part 4: Technology And Disease Feb 9, 2021
Scrip Asks…What Does 2021 Hold For Biopharma? Part 2: COVID-19 Shock Waves And Silver Linings Jan 25, 2021
New and Emerging Drug Classes That Will Outlast the Pandemic Dec 31, 2020
Pharma’s Almanac Roundtable: What do you think is the greatest lesson learned from the COVID-19 pandemic, and what lasting impacts do you foresee over the next 5–10 years? Dec 9, 2020
Pharma’s Almanac Roundtable: Although there is no such thing as a truly “crisis-proof” organization, how are you working to mitigate risks for future crises like the COVID-19 pandemic? Dec 9, 2020
Antiviral Conjugates – A Novel Treatment and Prevention Strategy for Viral Diseases Including COVID-19 Oct 14, 2020
Cidara Therapeutics Aims to Prevent Future COVID-19/Flu Season ‘Twindemics’ Oct 7, 2020
Long-Lasting Strategies for the Treatment and Prevention of COVID-19 Sep 2020
Companies To Watch: Cidara Therapeutics Aug 3, 2020
Why New Antifungals Are Desperately Needed July 29, 2020
Applying the Principles of Immunotherapy to Infectious Diseases July 1, 2020
Cidara Platforms Targeting Prophylactics and Treatments for Fungal, Viral Infections June 16, 2020
Hallelujah! A Universal Flu Preventative and Therapy with Jeff Stein, Cidara May 21, 2020
5 Biopharma Execs Reveal Corporate Culture Best Practices May 1, 2020
Developing respiratory therapeutics for prophylaxis and treatment Apr 30, 2020
Contagion Connect Episode 7 – The ID Pipeline: Rezafungin & Antiviral Fc-Conjugates Apr 2, 2020
Catching Up to Coronavirus: Top 60 Treatments in Development Mar 19, 2020
Yeast of burden: how to develop better antifungal drugs Mar 5, 2020
New Player In The Fight Against Resistant Fungal Infections In Phase 3 Trial Feb 26, 2020
Four new drugs may help fight the growing threat of fatal fungi Oct 22, 2019
The 2018 Flu Vaccine Was Only 29% Effective — but Experts Still Recommend It July 10, 2019
Preventing Invasive Fungal Infections in Hematologic Patients July 5, 2019
Cidara Advances Antiviral Conjugate to Treat and Prevent Flu May 17, 2019
Laszlo Majoros, MD, PhD: Rezafungin’s Activity Against Candida Species Apr 23, 2019
How long do vaccines last? The surprising answers may help protect people longer Apr 18, 2019
Cidara Developing Investigational Flu Antiviral Apr 18, 2019
Cidara Cloudbreak and Antiviral Conjugates Apr 18, 2019
Cloudbreak Antiviral Conjugate Demonstrates Potent In Vitro Activity Apr 16, 2019
Evaluating Cloudbreak Molecule for Protection Against Acinetobacter Pneumonia Apr 15, 2019
A Novel Influenza Antiviral in Development Could Offer Months of Illness Prevention Apr 4, 2019
FDA grants rezafungin QIDP and fast track designations Sep 28, 2018
Rezafungin safe, effective for treating candidemia, invasive candidiasis Jun 8, 2018
Growing resistance to antifungal drugs ‘a global issue’ May 18, 2018
Collaborating to Stem the Tide of Emerging Antimicrobial Resistance Aug 23, 2017
Think Fungus: Fungal Disease Awareness Week Aug 8, 2017
Jeff Stein and others explore the antifungal public health crisis and the need for next-generation antifungal treatments at the BIO International Convention June 20, 2017
Fungal Infections: Tricky to Spot, Diagnose and Manage May 3, 2017
Fighting Antimicrobial Resistance Calls for Collaboration Feb 13, 2017
The emerging battle against fungal infections – What healthcare organizations can do to help Jan 19, 2017
Jeffrey Stein, Ph.D., President and CEO of Cidara, Elected Chairman of the Antimicrobials Working Group Jan 11, 2017
Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s Disease Sep 20 2016
Antifungals in the Cloud Aug 25, 2016
New antifungal drugs profiled at Manchester fungal disease conference Mar 4, 2016
Cidara receives orphan drug status for antifungal to treat Candida infections Feb 11, 2016
Fighting Resistance With Novel Mechanisms of Action Feb 8, 2016
Top San Diego Financings of 2015 Feb 5, 2016
Hallelujah! A Universal Flu Preventative and Therapy with Jeff Stein, Cidara
Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth Jan 5, 2016
IDSA Updates Clinical Guidelines for Candidiasis: Shift to Echinocandins for Initial Treatment [Guidelines PDF; Press Release] Dec 17, 2015
Rallying the Forces: San Diego Business Journal Special Report On Cidara Sep 21, 2015

Antiviral Conjugates – A Novel Treatment and Prevention Strategy for Viral Diseases Including COVID-19 (via Technology Networks)